Overview of Salivart spray
The following quick facts define the identity and classification of Salivart spray.
| Property | Description |
|---|---|
| Active ingredients | Electrolyte salts, Carboxymethylcellulose, Glycerin |
| Form | Aerosol-spray (Oral/Mouth) |
| Pharmacological class | Saliva substitute / Oral Moisturizer |
| Common use | Relief of Dry mouth (Xerostomia) |
| Origin | Synthetic and Aqueous Combination Product |
What Type of Product is Salivart Spray? (Identity and Classification)
Salivart spray is classified as an Artificial Saliva product, which is a Synthetic Saliva Substitute and an Over-the-Counter (OTC) Oral Moisturizer. It is a device recognized by the FDA 510(k) K981693 and intended for the symptomatic management of Dry mouth (Xerostomia). It functions as a supportive Mouth and throat product designed to provide external moisture replacement, distinguishing it from prescription drugs that chemically stimulate residual salivary gland function. Its primary role is non-pharmacological replacement therapy, offering a supportive Saliva substitute option for patients with reduced salivary function.
Composition and Form: What is Synthetic Saliva Made Of?
The product is delivered as an Aerosol-spray formulation, utilizing an Aqueous base dispensed under pressure to ensure uniform coverage upon Oral/Mouth application. Salivart is a Combination product where the functional constituents include essential Electrolyte salts—such as Potassium Chloride and Sodium Chloride—engineered to approximate the ion profile of human saliva. The formula incorporates the polymer Carboxymethylcellulose and Glycerin to enhance viscosity, which is essential for improved Oral lubrication and a sustained protective effect on the oral mucosa.
General Purpose: What is Salivart Spray Used For?
The general purpose of the Saliva substitute is to deliver Oral lubrication and immediate Moistening/Hydrating oral mucosa to relieve the symptoms of discomfort associated with dryness in the mouth and Dry throat. By coating the oral tissues, the formulation creates a Protective film that effectively minimizes the friction and irritation accompanying severe Xerostomia. This action is aimed exclusively at providing symptomatic relief and improving the patient’s overall oral comfort, allowing individuals to speak and swallow with greater ease.
Regulatory References

